Results 211 to 220 of about 7,937 (220)
Some of the next articles are maybe not open access.
Alzheimer's disease: strategies for disease modification
Nature Reviews Drug Discovery, 2010Martin Citron
exaly
Transthyretin Gene Silencing in Amyloid Transthyretin Cardiomyopathy
Journal of the American College of CardiologyAmrut V. Ambardekar, Sarah A.M. Cuddy
openaire +1 more source
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
New England Journal of Medicine, 2018Chih-Chao Yang +2 more
exaly
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Nature Reviews Molecular Cell Biology, 2007exaly
Gamma frequency entrainment attenuates amyloid load and modifies microglia
Nature, 2016Annabelle C Singer +2 more
exaly
Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease
Nature, 2017Sathish Kumar +2 more
exaly
Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis
Science, 2003Rakez Kayed, Charles G Glabe
exaly
Specific Therapy in Transthyretin Amyloid Cardiomyopathy
Heart Failure ClinicsRiccardo Saro +5 more
openaire +1 more source
Acoramidis in Transthyretin Amyloid Cardiomyopathy. Reply.
The New England journal of medicineJulian D, Gillmore +2 more
openaire +1 more source